The interventional oncology market refers to the global industry of minimally invasive, image-guided medical procedures used to diagnose and treat cancer with targeted techniques such as ablation and embolization, offering faster recovery and fewer side effects than traditional surgery and systemic therapies.
According to FutureWise analysis, the Interventional Oncology Market in 2026 is US$3.01 billion and is expected to reach US$5.92 billion by 2036 at a CAGR of 7%. The Interventional Oncology Market focuses on minimally invasive, image-guided techniques used for the diagnosis and treatment of cancer. The market is experiencing significant growth driven by increasing demand for targeted cancer therapies and continuous advancements in imaging technologies. Currently, North America leads in market share, while the Asia-Pacific region is beginning to establish itself as a notable competitor in this field.
Growth Drivers:
- Rising incidence of cancer worldwide.
- Preference for minimally invasive and targeted therapies.
- Advances in imaging and interventional technologies.
- Increasing awareness and adoption of outpatient procedures.
- Growing healthcare infrastructure and investment in oncology care.
Key Trends:
- Growing adoption of image-guided ablation and embolization techniques.
- Integration of AI and advanced imaging for precise tumor targeting.
- Expansion of outpatient and minimally invasive oncology procedures.
- Rising collaborations between hospitals, research centers, and device manufacturers.
- Development of combination therapies integrating interventional oncology with immunotherapy.
Market Segmentation and Key Players:
The Interventional Oncology Market is segmented by product (including embolization devices like radioembolic and non-radioactive agents, ablation devices such as radiofrequency, microwave, and cryoablation tools, and support devices like microcatheters and guidewires), by procedure (e.g., thermal and non-thermal tumor ablation, transcatheter arterial chemoembolization and radioembolization), by cancer type (liver, lung, bone, kidney and others), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Comprehensive segmentation details are provided in the Segmentation section below.
Major companies operating in the Interventional Oncology market include Medtronic, Boston Scientific, and Terumo Corporation.
Research Methodology:
FutureWise Research methodology for the Interventional Oncology Market combines primary and secondary research. Primary research includes interviews and surveys with industry stakeholders to gather insights, while secondary research analyzes company reports, government publications, and industry journals to validate trends and market size. Market segmentation is examined by product, procedure, cancer type, and region, with quantitative data triangulated using various analytical tools.